<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE ep-patent-document PUBLIC "-//EPO//EP PATENT DOCUMENT 1.5//EN" "ep-patent-document-v1-5.dtd">
<ep-patent-document id="EP19812871A2" file="19812871.2" lang="en" country="EP" doc-number="3806831" kind="A2" date-publ="20210421" status="n" dtd-version="ep-patent-document-v1-5"><!-- This XML data has been generated under the supervision of the European Patent Office --><SDOBI lang="en"><B000><eptags><B001EP>ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSKBAHRIS..MTNORSMESMMAKHTNMD..........</B001EP><B003EP>*</B003EP><B005EP>X</B005EP><B007EP>BDM Ver 1.7.2 (20 November 2019) -  1100000/0</B007EP></eptags></B000><B100><B110>3806831</B110><B130>A2</B130><B140><date>20210421</date></B140><B190>EP</B190></B100><B200><B210>19812871.2</B210><B220><date>20190516</date></B220><B240><B241><date>20201218</date></B241></B240><B250>en</B250><B251EP>en</B251EP><B260>en</B260></B200><B300><B310>201808578</B310><B320><date>20180618</date></B320><B330><ctry>TR</ctry></B330></B300><B400><B405><date>20210421</date><bnum>202116</bnum></B405><B430><date>20210421</date><bnum>202116</bnum></B430></B400><B500><B510EP><classification-ipcr sequence="1"><text>A61K   9/51        20060101AFI20210112BHEP        </text></classification-ipcr><classification-ipcr sequence="2"><text>A61K  31/4704      20060101ALI20210112BHEP        </text></classification-ipcr><classification-ipcr sequence="3"><text>A61P  35/00        20060101ALI20210112BHEP        </text></classification-ipcr></B510EP><B540><B541>de</B541><B542>MIT CERANIB-2 BELADENE LIPIDNANOPARTIKEL ALS MITTEL GEGEN KREBS</B542><B541>en</B541><B542>LIPID NANOPARTICLES LOADED WITH CERANIB-2 AS ANTICANCER AGENTS</B542><B541>fr</B541><B542>NANOPARTICULES LIPIDIQUES CHARGÉES DE CERANIB -2, UTILISÉES EN TANT QU'AGENTS ANTICANCÉREUX</B542></B540></B500><B700><B710><B711><snm>Anadolu Universitesi</snm><iid>101697573</iid><irf>116-19960-A</irf><adr><str>Anadolu Universitesi Yunus Emre Kampusu</str><city>26470 Eskisehir</city><ctry>TR</ctry></adr></B711></B710><B720><B721><snm>KUTLU, Mehtap</snm><adr><str>Anadolu Universitesi Yunus Emre Kampüsü</str><city>26470 Tepebasi/Eskisehir</city><ctry>TR</ctry></adr></B721><B721><snm>KUS, Gökhan</snm><adr><str>Anadolu Universitesi Yunus Emre Kampüsü</str><city>26470 Tepebasi/Eskisehir</city><ctry>TR</ctry></adr></B721><B721><snm>ULUKAYA, Engin</snm><adr><str>Mürsel Mahallesi Yanki Sk. Belen Palm Country
Sitesi No:8</str><city>Mudanya/Bursa</city><ctry>TR</ctry></adr></B721></B720><B740><B741><snm>Mutlu, Aydin</snm><iid>101386015</iid><adr><str>Invokat Intellectual Property Services Ltd. 
Kartaltepe Mh. Yildiztepe Sk. 
No:6-Bakirköy</str><city>34145 Istanbul</city><ctry>TR</ctry></adr></B741></B740></B700><B800><B840><ctry>AL</ctry><ctry>AT</ctry><ctry>BE</ctry><ctry>BG</ctry><ctry>CH</ctry><ctry>CY</ctry><ctry>CZ</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>EE</ctry><ctry>ES</ctry><ctry>FI</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>GR</ctry><ctry>HR</ctry><ctry>HU</ctry><ctry>IE</ctry><ctry>IS</ctry><ctry>IT</ctry><ctry>LI</ctry><ctry>LT</ctry><ctry>LU</ctry><ctry>LV</ctry><ctry>MC</ctry><ctry>MK</ctry><ctry>MT</ctry><ctry>NL</ctry><ctry>NO</ctry><ctry>PL</ctry><ctry>PT</ctry><ctry>RO</ctry><ctry>RS</ctry><ctry>SE</ctry><ctry>SI</ctry><ctry>SK</ctry><ctry>SM</ctry><ctry>TR</ctry></B840><B844EP><B845EP><ctry>BA</ctry></B845EP><B845EP><ctry>ME</ctry></B845EP></B844EP><B848EP><B849EP><ctry>KH</ctry></B849EP><B849EP><ctry>MA</ctry></B849EP><B849EP><ctry>MD</ctry></B849EP><B849EP><ctry>TN</ctry></B849EP></B848EP><B860><B861><dnum><anum>TR2019050338</anum></dnum><date>20190516</date></B861><B862>en</B862></B860><B870><B871><dnum><pnum>WO2020018049</pnum></dnum><date>20200123</date><bnum>202004</bnum></B871></B870><B880><date>20200227</date><bnum>000000</bnum></B880></B800></SDOBI></ep-patent-document>